IntraBio and Levacetylleucine (AQNEURSA) updates

Cerebellar ataxia, Cerebellar ataxia pharma news, Research News, SCAs, Uncategorised /

IntraBio is a biopharmaceutical company focused on developing treatments for progressive neurological conditions. This page provides updates on their Levacetylleucine programme.    Levacetylleucine is a chemically modified version of the amino acid L-leucine. Amino acids […]

IntraBio and Levacetylleucine (AQNEURSA) updates Read More »